Connect your AI

Haemonetics HAE Investment Purchases

Investment Purchases at other companies

AbbottABT

$41.75M-1.2%

TFX

TeleflexTFX

$2.5M-50.0%

MedtronicMDT

$2.15B+0.9%

DanaherDHR

$20M+11.1%

GE HealthCare TechnologiesGEHC

$13M-35.0%

LeMaitre VascularLMAT

$150.87M+5,115%

Other financials

Income statement

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

Market cap$3.31B-18.0%

Profitability

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherInvestments.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Haemonetics's investment purchases?: Haemonetics (HAE) reported investment purchases of $0 in Q1 2026.
How has Haemonetics's investment purchases changed year-over-year?: Haemonetics's investment purchases decreased by 100.0% year-over-year, from $3.6M to $0.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.